Centene (NYSE:CNC) Price Target Raised to $67.00 at JPMorgan Chase & Co.

Centene (NYSE:CNC) had its price objective increased by equities researchers at JPMorgan Chase & Co. from $60.00 to $67.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target points to a potential upside of 4.39% from the company’s current price.

Other research analysts have also issued reports about the company. Oppenheimer upped their target price on Centene from $58.00 to $67.00 and gave the company an “outperform” rating in a research note on Wednesday, May 27th. UBS Group reiterated a “neutral” rating and set a $61.00 price target (up from $55.00) on shares of Centene in a research note on Friday, May 22nd. Truist Financial boosted their price target on shares of Centene from $71.00 to $78.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Mizuho set a $63.00 price objective on shares of Centene and gave the stock a “neutral” rating in a report on Monday, June 8th. Finally, Barclays reiterated an “overweight” rating and set a $80.00 target price (up from $75.00) on shares of Centene in a research report on Wednesday, July 29th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Centene currently has an average rating of “Hold” and an average price target of $68.58.

Centene Stock Performance

Shares of CNC traded up $0.42 during trading hours on Tuesday, reaching $64.18. 3,349,935 shares of the company traded hands, compared to its average volume of 6,094,552. Centene has a 1-year low of $25.08 and a 1-year high of $69.36. The stock has a market cap of $31.71 billion, a P/E ratio of -6.14, a price-to-earnings-growth ratio of 0.33 and a beta of 1.07. The stock’s fifty day moving average is $63.96 and its 200 day moving average is $50.42. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.15 and a current ratio of 1.15.

Centene (NYSE:CNC) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $2.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $1.42. Centene had a positive return on equity of 12.12% and a negative net margin of 2.51%.The firm had revenue of $53.58 billion for the quarter, compared to analyst estimates of $47.64 billion. During the same period in the previous year, the company posted ($0.16) earnings per share. The company’s quarterly revenue was up 9.9% compared to the same quarter last year. Centene has set its FY 2026 guidance at 4.800- EPS. Equities research analysts anticipate that Centene will post 4.89 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Centene

Large investors have recently made changes to their positions in the company. DV Equities LLC acquired a new position in Centene in the fourth quarter valued at about $26,000. IFC & Insurance Marketing Inc. bought a new position in shares of Centene in the fourth quarter valued at approximately $28,000. SBI Securities Co. Ltd. increased its holdings in Centene by 118.4% during the 4th quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock valued at $31,000 after purchasing an additional 406 shares in the last quarter. Bayban bought a new position in Centene in the 4th quarter valued at $33,000. Finally, MV Capital Management Inc. acquired a new position in Centene in the fourth quarter worth $34,000. Institutional investors own 93.63% of the company’s stock.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.